Overproduction of a certain molecule may lead to type 2 diabetes

03/13/2012 | Medical News Today

A study in Immunity revealed that damaged mitochondrial DNA in dying cells activates proteins that trigger the release of interleukin-1beta molecules, which may cause the onset of type 2 diabetes and other inflammatory diseases. The findings could lead to drugs that block the molecule's production instead of preventing interleukin-1beta's action after it is secreted, as current drugs do.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ